Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02LDV
|
|||
Drug Name |
Thiamine Hydrochloride
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Thiamine deficiency [ICD-11: 5B5A] | Approved | [1] | |
Wernicke-Korsakoff Syndrome [ICD-11: 5B5A.1] | Approved | [1] | ||
Therapeutic Class |
Neurology Agents
|
|||
Company |
Eli Lilly And Co
|
|||
Structure |
Download2D MOL
|
|||
Formula |
C12H18Cl2N4OS
|
|||
Canonical SMILES |
CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-]
|
|||
InChI |
1S/C12H17N4OS.2ClH/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13;;/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15);2*1H/q+1;;/p-1
|
|||
InChIKey |
DPJRMOMPQZCRJU-UHFFFAOYSA-M
|
|||
CAS Number |
CAS 67-03-8
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:49105
|
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.